Early research (Phase 1)WithdrawnNCT04548843
What this trial is testing
A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion
Who this might be right for
Primary Mitochondrial Diseases
Minovia Therapeutics Ltd.